Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds cytotoxic T-cell binding domain CD3 and CD20. Monoclonal antibodies have emerged as molecules for therapeutic intervention in a variety of disorders, additionally,  Monoclonal antibody-based targeted therapy has greatly improved treatment options for patients. However, targeting or neutralizing a single protein is not...